Reproducible flow cytometry data with lot-to-lot consistent recombinant antibodies

Recorded webinar

Despite its critical role for the production and release testing of cell products in modern cell therapies, flow cytometry remains a notoriously variable technique.

However, reproducibility and consistency are of key concern when monitoring cell production processes and releases of products, such as CAR T cell therapies. Therefore, it is essential that in-process control and quality control measures by flow cytometry fulfill essential standardization criteria.

 

Presenters: Kalpana Singh, Ph.D., Global Product Manager flow cytometry reagents, Miltenyi Biotec and Monika Maasem Panakova, Ph.D., Global Product Manager flow cytometry reagents, Miltenyi Biotec

Kalpana Singh, Ph.D., Miltenyi Biotec

Video

Reproducible flow cytometry data with lot-to-lot consistent recombinant antibodies

In the final webinar of this series, the following topics will be discussed: 

• Antibody-related reproducibility crisis and implications for antibody-based quality controls in cell manufacturing 
• Advances in recombinant antibody technology and opportunities for flow cytometry assays 
• Introduction of REAfinity™ Recombinant Antibodies and exemplary data in cell manufacturing assays